238 related articles for article (PubMed ID: 30419009)
1. HIV-1 capsids from B27/B57+ elite controllers escape Mx2 but are targeted by TRIM5α, leading to the induction of an antiviral state.
Merindol N; El-Far M; Sylla M; Masroori N; Dufour C; Li JX; Cherry P; Plourde MB; Tremblay C; Berthoux L
PLoS Pathog; 2018 Nov; 14(11):e1007398. PubMed ID: 30419009
[TBL] [Abstract][Full Text] [Related]
2. Correlates of spontaneous viral control among long-term survivors of perinatal HIV-1 infection expressing human leukocyte antigen-B57.
Tang Y; Huang S; Dunkley-Thompson J; Steel-Duncan JC; Ryland EG; St John MA; Hazra R; Christie CD; Feeney ME
AIDS; 2010 Jun; 24(10):1425-35. PubMed ID: 20539088
[TBL] [Abstract][Full Text] [Related]
3. Viral replication capacity as a correlate of HLA B57/B5801-associated nonprogressive HIV-1 infection.
Navis M; Schellens I; van Baarle D; Borghans J; van Swieten P; Miedema F; Kootstra N; Schuitemaker H
J Immunol; 2007 Sep; 179(5):3133-43. PubMed ID: 17709528
[TBL] [Abstract][Full Text] [Related]
4. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection.
Altfeld M; Addo MM; Rosenberg ES; Hecht FM; Lee PK; Vogel M; Yu XG; Draenert R; Johnston MN; Strick D; Allen TM; Feeney ME; Kahn JO; Sekaly RP; Levy JA; Rockstroh JK; Goulder PJ; Walker BD
AIDS; 2003 Dec; 17(18):2581-91. PubMed ID: 14685052
[TBL] [Abstract][Full Text] [Related]
5. TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection.
Chen H; Ndhlovu ZM; Liu D; Porter LC; Fang JW; Darko S; Brockman MA; Miura T; Brumme ZL; Schneidewind A; Piechocka-Trocha A; Cesa KT; Sela J; Cung TD; Toth I; Pereyra F; Yu XG; Douek DC; Kaufmann DE; Allen TM; Walker BD
Nat Immunol; 2012 Jun; 13(7):691-700. PubMed ID: 22683743
[TBL] [Abstract][Full Text] [Related]
6. HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition.
Miura T; Brockman MA; Schneidewind A; Lobritz M; Pereyra F; Rathod A; Block BL; Brumme ZL; Brumme CJ; Baker B; Rothchild AC; Li B; Trocha A; Cutrell E; Frahm N; Brander C; Toth I; Arts EJ; Allen TM; Walker BD
J Virol; 2009 Mar; 83(6):2743-55. PubMed ID: 19116253
[TBL] [Abstract][Full Text] [Related]
7. Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A.
Brockman MA; Schneidewind A; Lahaie M; Schmidt A; Miura T; Desouza I; Ryvkin F; Derdeyn CA; Allen S; Hunter E; Mulenga J; Goepfert PA; Walker BD; Allen TM
J Virol; 2007 Nov; 81(22):12608-18. PubMed ID: 17728232
[TBL] [Abstract][Full Text] [Related]
8. Changes in HIV-1 Capsid Stability Induced by Common Cytotoxic-T-Lymphocyte-Driven Viral Sequence Mutations.
Schommers P; Martrus G; Matschl U; Sirignano M; Lütgehetmann M; Richert L; Hope TJ; Fätkenheuer G; Altfeld M
J Virol; 2016 Aug; 90(16):7579-7586. PubMed ID: 27279617
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 viral escape in infancy followed by emergence of a variant-specific CTL response.
Feeney ME; Tang Y; Pfafferott K; Roosevelt KA; Draenert R; Trocha A; Yu XG; Verrill C; Allen T; Moore C; Mallal S; Burchett S; McIntosh K; Pelton SI; St John MA; Hazra R; Klenerman P; Altfeld M; Walker BD; Goulder PJ
J Immunol; 2005 Jun; 174(12):7524-30. PubMed ID: 15944251
[TBL] [Abstract][Full Text] [Related]
10. CD8+ T cells from HLA-B*57 elite suppressors effectively suppress replication of HIV-1 escape mutants.
Pohlmeyer CW; Buckheit RW; Siliciano RF; Blankson JN
Retrovirology; 2013 Dec; 10():152. PubMed ID: 24330837
[TBL] [Abstract][Full Text] [Related]
11. Impaired replication capacity of acute/early viruses in persons who become HIV controllers.
Miura T; Brumme ZL; Brockman MA; Rosato P; Sela J; Brumme CJ; Pereyra F; Kaufmann DE; Trocha A; Block BL; Daar ES; Connick E; Jessen H; Kelleher AD; Rosenberg E; Markowitz M; Schafer K; Vaida F; Iwamoto A; Little S; Walker BD
J Virol; 2010 Aug; 84(15):7581-91. PubMed ID: 20504921
[TBL] [Abstract][Full Text] [Related]
12. Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses.
Klein MR; van der Burg SH; Hovenkamp E; Holwerda AM; Drijfhout JW; Melief CJ; Miedema F
J Gen Virol; 1998 Sep; 79 ( Pt 9)():2191-201. PubMed ID: 9747728
[TBL] [Abstract][Full Text] [Related]
13. Immune escape precedes breakthrough human immunodeficiency virus type 1 viremia and broadening of the cytotoxic T-lymphocyte response in an HLA-B27-positive long-term-nonprogressing child.
Feeney ME; Tang Y; Roosevelt KA; Leslie AJ; McIntosh K; Karthas N; Walker BD; Goulder PJ
J Virol; 2004 Aug; 78(16):8927-30. PubMed ID: 15280502
[TBL] [Abstract][Full Text] [Related]
14. A nonprogressive clinical course in HIV-infected individuals expressing human leukocyte antigen B57/5801 is associated with preserved CD8+ T lymphocyte responsiveness to the HW9 epitope in Nef.
Navis M; Schellens IM; van Swieten P; Borghans JA; Miedema F; Kootstra NA; van Baarle D; Schuitemaker H
J Infect Dis; 2008 Mar; 197(6):871-9. PubMed ID: 18279072
[TBL] [Abstract][Full Text] [Related]
15. Structural and functional constraints limit options for cytotoxic T-lymphocyte escape in the immunodominant HLA-B27-restricted epitope in human immunodeficiency virus type 1 capsid.
Schneidewind A; Brockman MA; Sidney J; Wang YE; Chen H; Suscovich TJ; Li B; Adam RI; Allgaier RL; Mothé BR; Kuntzen T; Oniangue-Ndza C; Trocha A; Yu XG; Brander C; Sette A; Walker BD; Allen TM
J Virol; 2008 Jun; 82(11):5594-605. PubMed ID: 18385228
[TBL] [Abstract][Full Text] [Related]
16. Early HLA-B*57-restricted CD8+ T lymphocyte responses predict HIV-1 disease progression.
Brennan CA; Ibarrondo FJ; Sugar CA; Hausner MA; Shih R; Ng HL; Detels R; Margolick JB; Rinaldo CR; Phair J; Jacobson LP; Yang OO; Jamieson BD
J Virol; 2012 Oct; 86(19):10505-16. PubMed ID: 22811521
[TBL] [Abstract][Full Text] [Related]
17. Next-generation sequencing analyses of the emergence and maintenance of mutations in CTL epitopes in HIV controllers with differential viremia control.
Caetano DG; Côrtes FH; Bello G; Teixeira SLM; Hoagland B; Grinsztejn B; Veloso VG; Guimarães ML; Morgado MG
Retrovirology; 2018 Sep; 15(1):62. PubMed ID: 30201008
[TBL] [Abstract][Full Text] [Related]
18. Loss of HIV-1-derived cytotoxic T lymphocyte epitopes restricted by protective HLA-B alleles during the HIV-1 epidemic.
Schellens IM; Navis M; van Deutekom HW; Boeser-Nunnink B; Berkhout B; Kootstra N; Miedema F; Keşmir C; Schuitemaker H; van Baarle D; Borghans JA
AIDS; 2011 Sep; 25(14):1691-700. PubMed ID: 21681058
[TBL] [Abstract][Full Text] [Related]
19. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T
J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762
[TBL] [Abstract][Full Text] [Related]
20. Multiple transmissions of a stable human leucocyte antigen-B27 cytotoxic T-cell-escape strain of HIV-1 in The Netherlands.
Cornelissen M; Hoogland FM; Back NK; Jurriaans S; Zorgdrager F; Bakker M; Brinkman K; Prins M; van der Kuyl AC
AIDS; 2009 Jul; 23(12):1495-500. PubMed ID: 19487902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
